-
1 Comment
IMAC Holdings, Inc is currently in a long term uptrend where the price is trading 16.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
IMAC Holdings, Inc's total revenue sank by 18.4% to $3M since the same quarter in the previous year.
Its net income has increased by 113.1% to $190K since the same quarter in the previous year.
Finally, its free cash flow fell by 14.6% to $-2M since the same quarter in the previous year.
Based on the above factors, IMAC Holdings, Inc gets an overall score of 3/5.
Exchange | NASDAQ |
---|---|
CurrencyCode | USD |
Sector | Healthcare |
Industry | Healthcare Providers & Services |
ISIN | US44967K1043 |
Beta | -0.89 |
---|---|
Market Cap | 27M |
Target Price | 3.52 |
Dividend Yield | 0.0% |
PE Ratio | None |
IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IMAC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025